INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 158 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,797 | -22.9% | 2,049,220 | -0.5% | 0.01% | -25.0% |
| Q2 2023 | $84,028 | +20.6% | 2,060,491 | +10.2% | 0.01% | +20.0% |
| Q1 2023 | $69,687 | +3.5% | 1,869,761 | -3.1% | 0.01% | -9.1% |
| Q4 2022 | $67,315 | -99.9% | 1,929,355 | +11.1% | 0.01% | -31.2% |
| Q3 2022 | $97,218,000 | -8.3% | 1,737,260 | -15.1% | 0.02% | +23.1% |
| Q2 2022 | $105,970,000 | -34.3% | 2,047,331 | -7.8% | 0.01% | -18.8% |
| Q1 2022 | $161,318,000 | -35.0% | 2,219,871 | +5.7% | 0.02% | -27.3% |
| Q4 2021 | $248,345,000 | -21.0% | 2,100,348 | -10.4% | 0.02% | -26.7% |
| Q3 2021 | $314,520,000 | -21.9% | 2,344,538 | -5.7% | 0.03% | -18.9% |
| Q2 2021 | $402,588,000 | +115.8% | 2,486,491 | +7.0% | 0.04% | +94.7% |
| Q1 2021 | $186,552,000 | +61.7% | 2,324,490 | +9.6% | 0.02% | +58.3% |
| Q4 2020 | $115,376,000 | +298.1% | 2,120,883 | +45.5% | 0.01% | +300.0% |
| Q3 2020 | $28,985,000 | +1.9% | 1,458,005 | +7.7% | 0.00% | -25.0% |
| Q2 2020 | $28,447,000 | +10059.6% | 1,353,314 | +13139.2% | 0.00% | – |
| Q2 2018 | $280,000 | -77.5% | 10,222 | -82.7% | 0.00% | – |
| Q1 2018 | $1,243,000 | – | 58,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |